Cholesterol-lowering medication, n (%) | Calcium supplements, n (%) | Vitamins, n (%) | Bisphos-phonates, n (%) | Median time between stop and death in days [IQR] | |
---|---|---|---|---|---|
Stopped in total | 110 (48%) | 97 (61%) | 136 (56%) | 42 (70%) | |
Number of patients in whom the reason for discontinuing was documented | 28 (25%) | 23 (24%) | 13 (10%) | 9 (21%) | |
Numer of patients in whom the reason for discontinuing was not documented | 82 (75%) | 74 (76%) | 123 (90%) | 33 (79%) | |
Reasons | |||||
Medication review | 13 (12%) | 5 (5%) | 5 (4%) | 2 (5%) | 71 [16 -199] |
Undoubtedly in the terminal stage | 7 (6%) | 13 (13%) | 3 (2%) | 3 (7%) | 7 [3-13] |
Own initiative | 4 (4%) | 4 (4%) | 5 (4%) | 1 (2%) | 48 [15 – 122] |
Unable to take medication | 3 (3%) | 1 (1%) | 0 | 0 | 2 [1 – 34] |
Side effects | 1 (1%) | 0 | 0 | 3 (7%) | 312 [170 – 344] |